These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10956320)

  • 1. Modern management of hypertension and heart failure: evidence and practice.
    Hobbs FD
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i35-8; discussion i50. PubMed ID: 10956320
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
    Scheiner MA; Kimmel SE
    J Gen Intern Med; 1997 Sep; 12(9):581-2. PubMed ID: 9294792
    [No Abstract]   [Full Text] [Related]  

  • 3. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
    Houghton AR; Cowley AJ
    Int J Cardiol; 1997 Mar; 59(1):7-10. PubMed ID: 9080020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].
    González-Juanatey JR
    Med Clin (Barc); 2000; 114 Suppl 2():24-7. PubMed ID: 10916802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ACE inhibitors--an overview].
    Brüggmann J; Eberhardt C
    Fortschr Med; 1993 Jun; 111(16):283-5. PubMed ID: 8330827
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilisation of ACE inhibitors in patients with congestive heart failure.
    Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
    Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of chronic heart failure: how to reestablish a key role for the primary care physician?
    Goethals MA; Vanderheyden M
    Acta Clin Belg; 2004; 59(5):300-3. PubMed ID: 15641401
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Norcross WA
    West J Med; 1995 Jul; 163(1):67. PubMed ID: 7667987
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency.
    Ramirez LM
    Am J Hypertens; 2002 Sep; 15(9):832-3. PubMed ID: 12219882
    [No Abstract]   [Full Text] [Related]  

  • 12. Specialized heart failure centers--a success or an indicator of the failure of our health care delivery system.
    Pitt B; Nicklas JM
    Clin Cardiol; 2000 Dec; 23(12):881-2. PubMed ID: 11129672
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.
    Chin MH; Wang JC; Zhang JX; Lang RM
    J Gen Intern Med; 1997 Sep; 12(9):563-6. PubMed ID: 9294790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure].
    Hoyen HA; Alpert JS
    Cardiology; 1993; 82 Suppl 1():3-19. PubMed ID: 8519018
    [No Abstract]   [Full Text] [Related]  

  • 15. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?
    Bailey LJ; Naganathan V
    Med J Aust; 2007 Jan; 186(2):99-100; author reply 100-101. PubMed ID: 17223774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential therapy of heart failure. Which drug for which patient?].
    Schillinger W; Hermann HP; Hasenfuss G
    Internist (Berl); 2004 Dec; 45(12):1378-87. PubMed ID: 15526078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
    Sontheimer D; Hitchcock K; Saseen J
    J Fam Pract; 2007 Apr; 56(4):312-4. PubMed ID: 17403332
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors. Pharmacological and physiological background for cardiovascular treatment.
    Jerie P
    Cor Vasa; 1992; 34(1):31-66. PubMed ID: 1288942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiotensin converting enzyme inhibitor].
    Arakawa K
    Nihon Rinsho; 1991 Sep; 49(9):1978-83. PubMed ID: 1960865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.